Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization

Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization

US Patent 11180813 · Granted Nov 23, 2021

Estimated economic value: $52,217,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for diagnosing infectious disease and determining HLA status using immun2025
Methods for diagnosing infectious disease and determining HLA status using immun2025
Nucleic acid sequencing compositions and methods2025
Lyme disease-associated T cell receptor-related methods2025
T cell receptor sequences diagnostic for COVID-19 and related compositions2025
Efficiently characterizing protein-protein interactions2025
High-throughput screening methods to identify small molecule targets2025
Synthetic strands for nucleic acid sequencing and related methods and systems2025
Immunocompetence assessment by adaptive immune receptor diversity and clonality 2024
Immunocompetence assessment by adaptive immune receptor diversity and clonality 2024
Immunocompetence assessment by adaptive immune receptor diversity and clonality 2024
Immunocompetence assessment by adaptive immune receptor diversity and clonality 2024